This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Jingjun Yin, PhD
Executive Director at Merck Research Laboratories
Speaker

Profile

JJ Yin is Executive Director and head of the External Capabilities group within Merck Process Research & Development. JJ obtained his B.S. degree from University of Science and Technology of China and Ph.D. degree from Emory University. After postdoctoral studies at MIT, JJ joined Merck Process R&D in Rahway, NJ in 2001. JJ led various cross-functional teams at Merck to advance drug candidates from early development to commercialization. He also led teams to design efficient and novel catalysis screening platforms and technologies to solve challenging chemistry problems. His current team works with our strategic external partners to provide clinical drug substance supplies for Merck’s Pipeline across small and large molecule modalities. He has over 60 publications and patents.

Agenda Sessions

  • Nature-Inspired Continuous N-C Chain Elongation Enables Sustainable Peptide Manufacturing

    9:40am